Standards message here
Roger Lo, MD, PhD, a 2002 alumnus of the Tri-Institutional MD-PhD Program, is the recipient of the Inaugural American Association for Cancer Research (AACR)-Waun Ki Hong Award for Outstanding Achievement in Cancer Research. The Award was established in recognition of Dr. Hong's contributions to cancer research, cancer care, and cancer prevention during his career as a physician-scientist. The award commends a worthy cancer researcher who has conducted exemplary laboratory, translational, or clinical cancer research at a relatively early stage in his/her career. It honors the outstanding research of a young investigator who has not yet reached 46 years of age at the time of the award presentation. As recipient of the Award, Dr. Lo will receive an honorarium of $10,000, present a 30-35 minute lecture and be given full support to attend the AACR Annual Meeting 2017 in Washington, DC from April 1-5, 2017.
Dr. Lo has conducted pioneering research toward identifying the molecular underpinnings of metastatic melanoma and its response of therapy. As a result, his work has provided the major scientific rationale toward the use of inhibitors of BRAF and MEK in combination to effectively treat melanoma - a therapeutic approach that is now globally considered the standard of care. Dr. Lo is currently a professor in the Division of Dermatology/Department of Medicine and the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. he is also a member of the UCLA Jonsson Comprehensive Cancer Center, where his laboratory is located.